142 related articles for article (PubMed ID: 20155714)
1. Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma.
Barta I; Kullmann T; Csiszer E; Antus B
Int J Biol Markers; 2010; 25(1):52-6. PubMed ID: 20155714
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?
Carpagnano GE; Spanevello A; Palladino GP; Gramiccioni C; Ruggieri C; Carpagnano F; Foschino Barbaro MP
Lung Cancer; 2010 Jan; 67(1):108-13. PubMed ID: 19423183
[TBL] [Abstract][Full Text] [Related]
3. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
[TBL] [Abstract][Full Text] [Related]
4. Differential cytokine pattern in the exhaled breath of patients with lung cancer.
Kullmann T; Barta I; Csiszér E; Antus B; Horváth I
Pathol Oncol Res; 2008 Dec; 14(4):481-3. PubMed ID: 18415708
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath condensate pH in patients with lung cancer.
Antus B; Barta I
Lung Cancer; 2012 Feb; 75(2):178-80. PubMed ID: 21831475
[TBL] [Abstract][Full Text] [Related]
6. Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.
Bikov A; Lazar Z; Gyulai N; Szentkereszty M; Losonczy G; Horvath I; Galffy G
Lung; 2015 Dec; 193(6):957-63. PubMed ID: 26260979
[TBL] [Abstract][Full Text] [Related]
7. Epidermal Growth Factor in Exhaled Breath Condensate as Diagnostic Method for Non-Small Cell Lung Cancer.
Chen J; Chen J; Lv X; Yang Q; Yao S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819872271. PubMed ID: 31495334
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.
López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study.
Corradi M; Poli D; Banda I; Bonini S; Mozzoni P; Pinelli S; Alinovi R; Andreoli R; Ampollini L; Casalini A; Carbognani P; Goldoni M; Mutti A
J Breath Res; 2015 Jan; 9(2):027101. PubMed ID: 25634546
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
12. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
[TBL] [Abstract][Full Text] [Related]
13. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.
Han W; Wang T; Reilly AA; Keller SM; Spivack SD
Respir Res; 2009 Sep; 10(1):86. PubMed ID: 19781081
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma.
Jungraithmayr W; Frings C; Zissel G; Prasse A; Passlick B; Stoelben E
Respirology; 2008 Nov; 13(7):1022-7. PubMed ID: 18764914
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome.
Antus B; Barta I; Czebe K; Horvath I; Csiszer E
Inflamm Res; 2010 Jan; 59(1):83-6. PubMed ID: 20066781
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Feb; 10(1):016011. PubMed ID: 26866403
[TBL] [Abstract][Full Text] [Related]
17. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
18. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.
Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL
Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095
[TBL] [Abstract][Full Text] [Related]
19. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease.
Gessner C; Scheibe R; Wötzel M; Hammerschmidt S; Kuhn H; Engelmann L; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2005 Oct; 99(10):1229-40. PubMed ID: 16140223
[TBL] [Abstract][Full Text] [Related]
20. Exhaled matrix metalloproteinase-9 in lung cancer.
Carpagnano GE; Palladino GP; Martinelli D; Lacedonia D; Orlando S; Foschino-Barbaro MP
Rejuvenation Res; 2012 Aug; 15(4):359-65. PubMed ID: 22877564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
